ABC Money
Home

Green tea provides a ray of hope for leukemia patients

Green tea extract known as epigallocatechin gallate (EGCG) seemed to have improved the condition of four patients having chronic lymphocytic leukaemia (CLL) in the Mayo Clinic in the United States.

Published :
Sat, 24 Dec 2005 10:25
By : Richard Owen
Print this Story


AddThis Social Bookmark Button

Green tea extract known as epigallocatechin gallate (EGCG) seemed to have improved the condition of four patients having chronic lymphocytic leukaemia (CLL) in the Mayo Clinic in the United States.

In CLL, a blood and bone marrow cancer, white blood cells are affected. This is supposed to be the most common type of leukemia and normally occurs in persons above the age of 60.

The findings published online in Leukemia Research revealed that the patients showed signs of improvement after they took tablets containing EGCG.

At least, three of the four CLL patients showed signs of their cancer abating.

In fact, a Mayo Clinic study earlier found that EGCG kills leukemia cells which were taken from patients having CLL.

Study author and hematologist Dr. Tait Shanafelt said: “The experience of these individuals provides some suggestion that our previously published laboratory findings may actually translate into clinical effects for patients with the disease.”

He, however, said it was too early to draw any conclusions based on these results. He felt more studies needed to be carried out.

He added: “We do not know how many patients were taking similar products and failed to have any benefit. We also do not yet know the optimal dose that should be used, the frequency with which patients should take the medication, and what side effects will be observed with long-term administration.”

U.S. National Cancer Institute is sponsoring this study at Mayo clinic.

There is no cure as of now for this leukemia.

“The findings are interesting, but we cannot say yet this is a new treatment for cancer,” says Ken Campbell, clinical information officer at the Leukaemia Research Fund.


Share on


 You Might Like
Wallace & Co. keep Kylie company in hospital
Glaxo foresees explosive growth in vaccines market; plans 5 new vaccines
+
AstraZeneca announce record Q2 earnings, appoint David Brennan as CEO
Armstrong seals seventh Tour de France, bows out by winning Stage 20

Comment on this Article
Comment:
Title:
Name:
Please Enter
 
Here
  

 Search News

 Look For
Business
Credit cards
Finance
Loans
Money
Mortgages

 
 Stock Quotes *
SYMBOL
LAST
CHANGE
DOW JONES
8376.24
-215.45 ( -2.51 %)
NASDAQ
1445.56
-46.82 ( -3.19 %)
FTSE 100
4104.22
-59.39 ( -1.43 %)

SYMBOL ( 2007-09-26 )
LAST
CHANGE
NORTHERN ROCK ( 11:35am )
182.00
+19.04 ( 11.20 %)
GLAXOSMITHKLINE ( 3:34am )
1182.50
+11.00 ( 0.94 %)
SHIRE ( 3:33am )
937.50
+9.50 ( 1.02 %)
SMITH & NEPHEW ( 3:34am )
452.00
+9.25 ( 2.11 %)
TATE & LYLE ( 3:34am )
387.75
+8.00 ( 2.16 %)

SYMBOL ( 2008-12-04 )
LAST
CHANGE
MCDONALDS ( 4:00pm )
60.84
+1.29 ( 2.18 %)
JP MORGAN CHASE CO ( 4:01pm )
31.08
+0.83 ( 2.78 %)
WAL MART STORES ( 4:02pm )
55.11
+0.73 ( 1.32 %)
HOME DEPOT INC ( 4:00pm )
23.22
+0.46 ( 2.05 %)
DUPONT ( 4:01pm )
23.69
+0.08 ( 0.36 %)

SYMBOL ( 2008-12-04 )
LAST
CHANGE
SANDERSON FARMS IN ( 4:00pm )
30.46
+4.84 ( 21.70 %)
C&F FINANCIAL CORP ( 3:48pm )
19.16
+4.55 ( 31.36 %)
DECKERS OUTDOOR CP ( 4:00pm )
62.70
+4.32 ( 7.53 %)
COPART INC ( 4:00pm )
26.91
+3.51 ( 14.73 %)
SEARS HOLDINGS CORPORATION ( 4:00pm )
41.04
+3.36 ( 9.08 %)

Gainers & Losers
Dow Jones
Euro Stoxx 50
FTSE 100
FTSE 250
FTSE AIM
FTSE ALL
Nasdaq

 Portfolio Manager

You must log in to access this area of the site. If you are not a registered user click here to sign up for instant access!


 Finance Explained

Money making ideas

Save money

Money management
Savings accounts
Investing money
Share dealing
Stock broker
Forex currency trading
Pension plans
Functions of Money

(c) 2007 ABCmoney.co.uk, All Rights Reserved
*ABCMoney.co.uk does not guarantee the accuracy of any share prices or stock quotations displayed. These are not real time quotes; all are delayed by at least twenty minutes and are for information purposes only.